Anika Therapeutics, Inc.: Form SC 13D/A, filed Mar 6, 2024
Filed with the SEC on Mar 6, 2024 and accepted by EDGAR at Mar 6, 2024, 19:30 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000902664-24-002242. Last ingested by Listed: Oct 24, 2026, 15:00 ET. Listed shows no prices and gives no investment advice.